Merck moves into obesity with deal for Hansoh’s GLP-1 pill
Dive Brief: Merck & Co. has made its first big move in obesity treatment, announcing Wednesday it is paying Hansoh Pharma $112 million for rights outside China to a preclinical pill that works similarly to the popular injection Wegovy. Per deal terms, …